NIH Director Says Precision Medicine Requires Transparency And Exquisite Data

March 7, 2015 9:01 AM

8 0

Dr. Francis Collins, the director of the National Institutes of Health, indicated that the data harnessed by Obamacare’s Precision Medicine Initiative will require software transparency and what he called “exquisite” data to be pieced together from existing studies.

The $215 million precision medicine program has a panel assigned to sorting out the details which is lead by Yale geneticist Dr. Richard Lifton and NIH Deputy Director Kathy Hudson.

Also read: Uncertainty in Italy After Vote

Read more

To category page

Loading...